Repository logo
 
No Thumbnail Available
Publication

SAFETY AND EFFICACY OF DOLUTEGRAVIR BASED TRIPLE THERAPY IN HIV-2 INFECTION

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

Database solution for an HIV-2 cohort study Publication "Real-world experience of TAF/FTC/BIC in people with HIV-2" presented at European AIDS Clinical Society Conference, Oct 2023, Warsaw HIV-2 salvage therapy with Lenacapavir (injectable, capsid inhibitor, EMA approved 2022)

Description

Keywords

HIV-2 INFECTION DOLUTEGRAVIR Premio cientifico

Citation

Research Projects

Organizational Units

Journal Issue

Publisher

CC License